Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Botanical and Plant-Derived Drugs - Analysis, Trends & Forecasts to 2022 - Research and Markets

Research and Markets
Posted on: 12 Dec 17

The "Botanical and Plant-Derived Drugs: Global Markets" report has been added to Research and Markets' offering.

The Global Market for Botanical and Plant-Derived Drugs will Grow from $29.4 Billion in 2017 to around $39.6 Billion by 2022 with a CAGR of 6.1%.

This report is an analytical business tool whose primary purpose is to describe the botanical drug industry with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.

For the purposes of this report, botanicals are those drugs that are FDA-approved under the botanical drug pathway, while plant-derived drugs are both botanicals as well as other approved drugs that contain a mixture of natural plant-derived and synthetic or semisynthetic substances.

The study's main focus is on legal, prescription-required therapeutic medicines sold in the open market. The study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall wellness rather than to address a specific medical condition or symptoms). While there is a substantial market for these products, the medical value of many of these substances has not been demonstrated conclusively.

The Format Of The Study Is Organized Around The Following Topics:

  • Major types and applications of botanical drugs with plant-derived drugs as their backdrop.
  • Industry structure.
  • Market size and segmentation, including the breakdown of sales by therapeutic area and geographic area.
  • Market drivers.
  • Market projections through 2022.
  • Competition.
  • Observations and conclusions regarding the future of the botanical and plant-derived drug industry.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

  • Trends and Drivers for Botanical Drug Development

3: Market and Technology Background

  • Brief History of Plant-Derived Medicines
  • Opportunity Lies Beyond What Is Known
  • Getting Started
  • Key Drivers
  • Key Challenges
  • U.S. Government Investment
  • Industry Investment
  • Nutrition Science Partners Ltd. (Nestle Health): A Case Study
  • Botanical Drugs Defined
  • Understanding the Regulatory Process
  • Investigational New Drug Applications
  • The First and Second U.S. Approved Botanical Drug
  • Botanical Candidates in the Pipeline
  • A Growing Pipeline
  • Overall Pharma Landscape
  • Major Classes of Plant Drugs
  • Intellectual Property
  • Production
  • A New Type of Production: Plant-Made Drugs
  • Drug Development and Manufacture

4: Market Breakdown by Technology Type

  • Sales of Plant-derived Drugs by Region
  • Plant-derived Drugs by Therapeutic Area
  • Value of Plant-derived Drugs by Therapeutic Area
  • A Pipeline Perspective: Composition of Botanical Drugs in Clinical Development

5: New Developments and Market Opportunities

  • Hormone Therapy and Metabolism Applications
  • Infectious Disease Applications
  • Pain and Central Nervous System Disease Applications
  • Cardiovascular and Metabolic Applications
  • Respiratory, Inflammation (Both Nonrelated and Related to Orthopedic) and Autoimmune Applications
  • Dermatology Applications
  • Gastrointestinal Applications
  • Oncology Applications
  • Botanical Drugs in Clinical Development

6: Company Profiles

  • Abbott Laboratories
  • Artecef BV
  • Bayer Healthcare Pharmaceuticals
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cardax Pharmaceuticals
  • Chi-Med
  • Chong Kun Dang Pharmaceutical Corp.
  • Eli Lilly
  • Fytokem Products Inc.
  • Galapagos Nv
  • Glaxosmithkline
  • Glenmark Pharmaceuticals Limited
  • Heterogeneity Llc
  • Hsrx Biopharmaceutical
  • Indena
  • Others

For more information about this report visit https://www.researchandmarkets.com/research/573kc3/botanical_and

View source version on businesswire.com: http://www.businesswire.com/news/home/20171212005666/en/

Business Wire
www.businesswire.com

Last updated on: 12/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.